Modest effect of delgocitinib to recalcitrant chronic hand eczema
Clinical and Experimental Dermatology · 11.11.2026
DOI: 10.1093/ced/llag472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 11.11.2026. Verfasst von Malin Glindvad Ahlström und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark.
Abstract (Originalsprache)
Topical delgocitinib demonstrated limited efficacy after 8 weeks of treatment in 14 patients with chronic, treatment-resistant moderate-to-severe chronic hand eczema (CHE). The observed treatment response was lower than that reported in previous clinical trials, and no significant predictors of response were identified.
Autor:innen und Institutionen
- Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- National Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
ORCID-Profile: Malin Glindvad Ahlström, Lone Skov
Zitieren
APA
Ahlström, M. G., Skov, L., Schwensen, J. F., & Zachariae, C. (2026). Modest effect of delgocitinib to recalcitrant chronic hand eczema. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag472
Vancouver
Ahlström MG, Skov L, Schwensen JF, Zachariae C. Modest effect of delgocitinib to recalcitrant chronic hand eczema. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag472
BibTeX
@article{Ahlstrm2026,
author = {Ahlström, Malin Glindvad and Skov, Lone and Schwensen, Jakob Ferløv and Zachariae, Claus},
title = {Modest effect of delgocitinib to recalcitrant chronic hand eczema},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag472}
}
EUVIMED